Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs

Drug Discovery Today

Volumn 19, Issue 11, 2014, Pages 1801-1807

  Santos, Gustavo R C ^a   Tovar, Ana M F ^a   Capillé, Nina V M ^a   Pereira, Mariana S ^a   Pomin, Vitor H ^a   Mourão, Paulo A S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANION EXCHANGE CHROMATOGRAPHY; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CATTLE; DRUG STRUCTURE; DRUG SULFATION; EXPERIMENTAL THROMBOSIS; FRACTIONATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; STRUCTURE ACTIVITY RELATION; SWINE; ANIMAL; BOVINE; CHEMICALLY INDUCED; CHEMISTRY; INTESTINE MUCOSA; PIG; THROMBOSIS;

ANIMALS; ANTICOAGULANTS; CATTLE; HEMORRHAGE; HEPARIN; HUMANS; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; SWINE; THROMBOSIS;

EID: 84910652229     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.07.004     Document Type: Review

References (19)

1. R. Norma 100 years, Looking back. Skill, drive and luck: the discovery and development of heparin CMAJ 13 2011 2139 2140
2. B. Mulloy Characterization of unfractionated heparin: comparison of materials from the last 50 years Thromb. Haemost. 84 2000 1052 1056
3. G. Tagarakis, and N.B. Tsilimingas Heparin-coated extracorporeal circulation systems in heart surgery Recent Pat. Cardiovasc. Drug Discov. 4 2009 177 179
4. B. Molito Monitoring of the heparin therapy during acute haemodialysis Haemostaseologie 25 2005 272 278
5. E. Gray Heparin and low-molecular-weight heparin Thromb. Haemost. 99 2008 807 818
6. T.W. Barrowcliffe History of heparin R. Lever, Heparin - A Century of Progress 2012 Springer 4 19
7. D.L. Rabenstein Heparin and heparan sulfate: structure and function Nat. Prod. Rep. 19 2002 312 331
8. A.S. Perlin, and L.W. Mazurek A proton magnetic resonance spectral study of heparin. l-Iduronic acid residues in commercial heparins Carbohydr. Res. 7 1968 369 379
9. W.D. Markiewicz 1 GHz NMR spectroscopy: innovation in magnetic technology Solid State Nucl. Magn. Reson. 9 1997 73 76
10. V.H. Pomin Solution NMR conformation of glycosaminoglycans Prog. Biophys. Mol. Biol. 114 2014 61 68
11. T.R. Rudd The conformation and structure of GAGs: recent progress and perspectives Curr. Opin. Struct. Biol. 20 2010 567 574
12. L. Nieto Conformational selection of the AGA∗IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor Chem. 17 2011 11204 11209
13. D. Loganathan Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources Biochemistry 29 1990 4362 4369
14. L. Fu Structural characterization of pharmaceutical heparins prepared from different animal tissues J. Pharm. Sci. 102 2013 1447 1457
15. R.S. Aquino Heparins from porcine and bovine intestinal mucosa: are they similar drugs? Thromb. Haemost. 103 2010 1005 1015
16. A.M.F. Tovar Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects Thromb. Haemost. 107 2012 903 915
17. A.M.F. Tovar Bovine and porcine heparins: different drugs with similar effects on human haemodialysis BMC Res. 6 2013 230
18. M. Petitou 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site Biochimie 85 2003 83 89
19. E.I. Melo Heparin quality control in the Brazilian market: implications in the cardiovascular surgery Rev. Bras. Cir. Cardiovasc. 23 2008 169 174